Previous close | 73.76 |
Open | 74.03 |
Bid | 74.77 x 100 |
Ask | 75.04 x 100 |
Day's range | 73.28 - 76.39 |
52-week range | 55.02 - 98.40 |
Volume | |
Avg. volume | 727,375 |
Market cap | 3.557B |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
In this article, we will be taking a look at the 15 most black states in the US. If you do not want to learn about the demographics of global black population, head straight to the 5 Most Black States in the US. Overview of the Global Black Population: Demographics, Trends, and Immigration Patterns The […]
Axsome's (AXSM) phase III ENGAGE study is set to evaluate the efficacy and safety of solriamfetol for the treatment of binge eating disorder in adults.
Axsome Therapeutics Inc (NASDAQ:AXSM), a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS) disorders, has reported an insider sell according to a recent SEC filing.